文献速递慢阻肺

7至53岁FEF25-75%轨迹及其与童年和父母孕前因素及中年COPD风险的关联:一项前瞻性队列研究

FEF25-75% trajectories from age 7 to 53 years, associations with childhood and parental preconception factors, and midlife COPD risk: a prospective cohort study.
PubMed 文献 · Lancet Respir Med · 2026-07-21

该前瞻性队列纳入2314名 offspring,从7岁随访至53岁,识别出6种FEF25-75%轨迹,其中三种受损轨迹与COPD风险升高相关,并发现童年因素及父母孕前因素与轨迹相关。

要点

  • FEF25-75%轨迹可分为6类,三种受损轨迹与53岁时COPD风险增加相关。
  • 持续低轨迹的COPD调整OR为112(95%CI 42-304)。
  • 童年哮喘、肺炎及父母孕前吸烟等因素与受损轨迹相关。

核心结论

  • FEF25-75%全生命周期轨迹,尤其是早期轨迹,可能与COPD的相关性超过既往认识。
  • 多种童年因素和新的父母孕前因素与FEF25-75%轨迹相关,但因时间关联不明确不能推断因果。
  • FEF25-75%与COPD的关系应解释为生命程关联而非预测性关联。

研究设计与样本

  • 前瞻性队列研究,纳入Tasmanian Longitudinal Health Study的2314名 offspring。
  • 7岁时测量支气管舒张前FEF25-75%,随访至平均53岁。
  • 采用基于组的轨迹模型识别FEF25-75%轨迹,回归模型评估关联。

主要发现

  • 与受损轨迹相关的因素包括未母乳喂养、童年哮喘或喘息、过敏性鼻炎、肺炎或胸膜炎、母亲哮喘或喘息、父母孕前吸烟。
  • 持续高轨迹与父母孕前微生物相关暴露相关(如父亲童年与三个或以上兄弟姐妹共享卧室、母亲青春期前养猫)。

关键数值与推荐

  • COPD风险按53岁时评估。
  • 轨迹分组依据FEF25-75%的基于组轨迹模型。

临床怎么用

  • 临床可关注FEF25-75%轨迹评估COPD风险,尤其早期肺功能轨迹。
  • 识别童年哮喘、肺炎及父母孕前吸烟等可干预因素可能有助于风险分层。
  • FEF25-75%与COPD的关联为生命程关联,不宜直接用于个体预测。

局限性

  • 因关联时间性不明确,不能推断因果关系。
  • 平均轨迹中COPD罕见,效应估计值可能被放大。
  • FEF25-75%与COPD的关系应解释为生命程关联而非预测性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Existing trajectory studies have emphasised large-airway indices, but chronic obstructive pulmonary disease (COPD) might originate in smaller airways. This study aimed to investigate mid-to-small-airway function trajectories, their associated factors, and COPD risk. METHODS: In this prospective cohort study, probands (referred to throughout as offspring) were recruited to the Tasmanian Longitudinal Health Study from local schools across Tasmania, Australia at age 7 years. Pre-bronchodilator mean forced expiratory flow between 25% and 75% of the forced vital capacity (FEF25-75%) of offspring was measured at age 7 years as a proxy measure of mid-to-small-airway function. Parents completed a comprehensive respiratory health survey on themselves and their offspring. Offspring were followed up at mean ages of 13, 18, 45, 50, and 53 years. Follow-up included pre-bronchodilator spirometry, demographic surveys, lifestyle factors, respiratory symptoms, and illnesses. Post-bronchodilator spirometry was measured at mean ages of 45 and 53 years. Parents were later approached to complete the 2010 Tasmanian Longitudinal Health Study Parents Postal Survey, which collected information on parental preconception factors, including exposures during their own childhood and adolescence. Group-based trajectory modelling was used to identify FEF25-75% trajectories. Regression models were used to assess associations of FEF25-75% trajectories with childhood and parental preconception factors, and with COPD risk by age 53 years. FINDINGS: Between Feb 23, 1968, and Nov 8, 2016, 2314 offspring from the Tasmanian Longitudinal Health Study were included. Six FEF25-75% trajectories were identified: persistently low (144 [6·2%]); early normal-reduced growth-rapid decline (168 [7·3%]); early below average-reduced growth (740 [32·0%]); early low-accelerated growth (80 [3·5%]); average (976 [42·2%]; reference); and persistently high (206 [8·9%]). Three impaired trajectories across the lifespan were associated with COPD: persistently low (adjusted odds ratio 112 [95%CI 42-304]), early normal-reduced growth-rapid decline (41 [15-112]), and early below average-reduced growth (3·1 [1·0-9·2]) trajectories. Factors associated with impaired trajectories included no breastfeeding, the presence of asthma or wheeze, allergic rhinitis, and pneumonia or pleurisy during childhood, maternal asthma or wheeze, and parental smoking before conception. The persistently high trajectory was associated with parental preconception microbial-related exposures (ie, fathers sharing a childhood bedroom with three or more siblings and maternal cat keeping before completing puberty). INTERPRETATION: FEF25-75% across the life course, particularly from early life, could be more relevant to COPD than previously recognised. Several childhood and novel parental preconception factors were associated with FEF25-75% trajectories, although causality cannot be inferred due to no clear temporality of these associations. Our findings on the relationship between FEF25-75% and COPD should be interpreted as life-course associations rather than as predictive. As COPD was rare in the average trajectory, the magnitude of effect estimates could be inflated. FUNDING: National Health and Medical Research Council of Australia; The University of Melbourne; Clifford Craig Medical Research Trust; the Victoria, Queensland, and Tasmania Asthma Foundations; The Royal Hobart Hospital Research Foundation; Helen MacPherson Smith Trust; GlaxoSmithKline; China Scholarship Council.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Liu J, Lodge CJ, Perret JL, et al. FEF25-75% trajectories from age 7 to 53 years, associations with childhood and parental preconception factors, and midlife COPD risk: a prospective cohort study. Lancet Respir Med. 2026. PMID: 42480573. doi:10.1016/S2213-2600(26)00163-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。